Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology

C. Stegmayr, G. Stoffels, C. Filss, A. Heinzel, P. Lohmann, A. Willuweit, J. Ermert, H.H. Coenen, F.M. Mottaghy, N. Galldiks, K.J. Langen

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)78-84
Number of pages7
JournalNuclear Medicine and Biology
Publication statusPublished - 1 Jan 2021


  • brain metastasis
  • brain tumor diagnosis
  • cerebral glioma
  • o-(2-[f-18]fluoroethyl)-l-tyrosine (fet)
  • pet
  • radiolabelled amino acids
  • Brain tumor diagnosis
  • Brain metastasis
  • Radiolabelled amino acids
  • Cerebral glioma
  • PET
  • O-(2-[F-18]fluoroethyl)-L-tyrosine (FET)

Cite this